SlideShare a Scribd company logo
1 of 43
Multiple dosing: intravenous bolus
administration
Multiple IV Bolus Dose
Administration
 Objectives:
 1) To understand drug accumulation
after repeated dose administration
 2) To recognize and use the
integrated equations used to
describe plasma concentrations
versus time after multiple IV. doses
 3) To calculate appropriate multiple
dose drug regimen
2
Multiple-Dosage Regimens:
 After single-dose drug administration, the
plasma drug level rises above and then
falls below the minimum effective
concentration (MEC)  decline in
therapeutic effect.
 To maintain prolonged therapeutic
activity, many drugs are given in a
multiple-dosage regimen.
 The plasma levels of drugs given in
multiple doses must be maintained within
the narrow limits of the therapeutic
window
3
 Ideally, a dosage regimen is established for
each drug to provide the correct plasma level
without excessive fluctuation and drug
accumulation outside the therapeutic
window.
 Some drugs that have a narrow therapeutic
range (eg, digoxin and phenytoin) require
definition of the therapeutic minimum and
maximum nontoxic plasma concentrations
(MEC and MTC).
4
Multiple dosing calculations using
Superposition
Let:
Dose 1  Conc. 1
and:
Dose 2  Conc. 2
then the response system behaves according to
the superposition principle if:
Dose 1 +Dose 2  Conc. 1 + Conc. 2
and in that case the response system is a linear
response system
5
Multiple dosing calculations using
Superposition
 A patient is to be given 100 mg of a
drug intravenously. Assuming that K
= 0.10 hr-1 and a V = 15 L,
estimate the following:
1. The half life
hr
hr
K
t 93
.
6
1
.
0
)
2
ln(
)
2
ln(
2
/
1 


6
Multiple dosing calculations using
Superposition
2. The concentration 2 hrs after the dose
3. The concentration 10 hrs after the
dose
mg/L
5.46
D
)
2
( )
2
(


 

 t
K
e
V
t
C
mg/L
2.45
D
)
10
( )
10
(


 

 t
K
e
V
t
C
7
Multiple dosing calculations using
Superposition
4. The concentration 18 hrs after the
dose
mg/L
10
.
1
D
)
18
( )
18
(


 

 t
K
e
V
t
C
8
9
0
1
2
3
4
5
6
7
0 8 16 24 32
Conc.
(mg/L)
Time (hr)
Multiple dosing calculations using
Superposition
5. Assuming that 100 mg of the drug is
administered every 8 hrs, estimate
the concentration 2 hrs after the third
dose using the values calculated in
parts 2-4. What property of the linear
systems did you use to answer this
question?
10
0
2
4
6
8
10
12
0 8 16 24 32
Conc.
(mg/L)
Time (hr)
Conc. After the first dose
)
(
1 t
C
11
0
2
4
6
8
10
12
0 8 16 24 32
Conc.
(mg/L)
Time (hr)
Conc. After the second dose
)
(
2 t
C
12
0
2
4
6
8
10
12
0 8 16 24 32
Conc.
(mg/L)
Time (hr)
Conc. After the third dose
)
(
3 t
C
13
0
2
4
6
8
10
12
0 8 16 24 32
Conc.
(mg/L)
Time (hr)
Total Conc.
)
'
(
3 t
Cn
14
0
2
4
6
8
10
12
0 8 16 24 32
Conc.
(mg/L)
Time (hr)
)
2
(
)
10
(
)
18
(
)
2
'
( 3
2
1
3 






 t
C
t
C
t
C
t
Cn
t = 2 hrs after third dose
= 10 hrs after second dose
= 18 hrs after first dose
15
Multiple dosing calculations using
Superposition
5. Assuming that 100 mg of the drug is
administered every 8 hrs, estimate the
concentration 2 hrs after the third dose
using the values calculated in parts 2-4.
What property of the linear systems did
you use to answer this question?
mg/L
01
.
9
)
2
'
(
46
.
5
45
.
2
10
.
1
)
2
'
(
)
2
(
)
10
(
)
18
(
)
2
'
(
3
3
3
2
1
3
















t
C
t
C
t
C
t
C
t
C
t
C
n
n
n
16
1
7
1
8
1
9
2
0
Multiple dosing calculations using
Superposition
 The principle of superposition assumes
that early doses of drug do not affect the
pharmacokinetics of subsequent doses.
 Therefore, the blood levels after the
second, third, or nth dose will overlay or
superimpose the blood level attained after
the (n – 1)th dose
Multiple administration every 4 hrs
Dose
Number
Time
(hr)
Dose 1 Dose 2 Dose 3 Dose 4 Total
1 0 0 0
1 21.0 21.0
3 19.8 19.8
2 4 16.9 0 16.9
5 14.3 21.0 35.3
7 10.1 19.8 29.9
3 8 8.50 16.9 0 25.4
9 7.15 14.3 21.0 42.5
11 5.06 10.1 19.8 35.0
4 12 4.25 8.50 16.9 0 29.7
13 3.58 7.15 14.3 21.0 46.0
15 2.53 5.06 10.1 19.8 37.5
2
3
2
4
Multiple IV bolus administration
 Concentration after n doses:
where r:
n: number of doses, T: dosing interval






 
 )
(
D t
K
n e
V
r
C
KT
nKT
e
e
r 




1
1
Multiple IV bolus administration: useful
equations
 Maximum concentration after n doses:
 Maximum concentration at steady state:







V
R
CSS
D
max







V
r
CN
D
max
Multiple IV bolus administration: useful
equations
 Minimum concentration after n doses:
 Minimum concentration at steady state:







 KT
e
V
R
CSS
D
min







 KT
e
V
r
CN
D
min
Multiple IV bolus administration
 Concentration at steady state:
where R is the accumulation ratio:
T: dosing interval






 
 )
(
D t
K
ss e
V
R
C
KT
e
R 


1
1
Conc time profile:
The AUC during a dosing interval at
steady state is equal to the total AUC
following a single dose (For linear PK)
AUC for a single dose is:
As explained in the previous slide,
Multiple IV bolus administration: useful
equations
 Average concentration at steady state:



 0
.dt
C
C
SS
average
SS

KVd
X
Caverage
SS
0





0
τ
0
SS dose).dt
C(single
.dt
C
KVd
X0
0
dose).dt
C(single 


Predicting average Css using single
dose data
Time to reach steady state conc.
 The time required to reach to a certain
fraction of the steady-state level is given
by:
 Time required to achieve steady-state
depends on the half-life and is
independent of the rate of dosing and the
clearance
 To get to 95% of the steady-state: 5 half-
lives are needed
 To get to 99% of the steady-state: 7 half-
lives are needed
)
1
ln(
44
.
1 5
.
0 fss
t
n 



Different doses regimen have the same
average steady state conc: The same dosing
rate (Dose/ T)
Multiple IV bolus dosing compared to
IV infusion
Multiple IV
bolus
IV infusion
Multiple IV bolus dosing compared to
IV infusion
 For IV infusion:
 For multiple IV bolus (dosing rate =
dose/ dosing interval):
 The steady-concentration depends
on the rate of dosing and the
clearance
clearance
rate
Dosing
0


KVd
K
Caverage
SS
clearance
rate
dosing
0



KVd
X
Caverage
SS
Example 1
 To a patient 250 mg penicillin with t½ of
1 h and Vd of 25 L is administered every
6 h intravenously
1. Estimate Cmax, Cmin and Cav at steady
state
2. Has the objective of maintaining
concentration above minimum inhibitory
concentration (4 mg/L) been achieved in
this therapy? Elaborate!
3. How long did it take to reach 95% of Css?
4. Is the idea of giving a bolus dose to
achieve Css in a shorter time feasible
with regard to this drug?
Example 1
016
.
1
1
1
1
1
6
*
693
.
0




 

e
e
R KT
1
0.5
hr
0.693
1
0.693
t
0.693
K 



mg/L
10.16
25
250
1.016
V
D
R
Cmax
SS















mg/L
0.16
e
25
250
1.016
e
V
D
R
C *6
0.693
KT
min
SS
















 

mg/L
2.41
6
*
25
*
0.693
250
KVdτ
X
C 0
average
SS



Example 1
 Drug concentration cannot be maintained above
the MIC if it is being administered every 6 h (6 x
t½). Because almost 98% of the dose is out of
the body at the time of the next administration.
However, conventionally penicillins are given
q.i.d. and it is known that they are effective.
Therefore, there is no need for keeping the
concentration above MIC during the entire
therapy.

 4.3 hrs are needed to get to 95% of Css (i.e.
Css was obtained as a result of the first dose)
hr
4.3
0.95)
ln(1
*
1.44
fss)
ln(1
t
1.44
*
1
0.5
nτ
nτ







Example 1
 The steady-state is achieved very
rapidly (after the first dose). Since
there is no need for accumulation,
there is little justification for giving
a loading dose.
Example 2
 A patient is receiving 1000 mg of
sulfamethoxazole iv every 12 hours
for the treatment of severe gram-
negative infection. At steady state
the maximum and minimum serum
sulfamethoxazole concentrations
were 81.5 mg/L and 40 mg/L,
respectively. Estimate the values of
K and VD
Example 2
T
C
C
t
t
C
C
K SS
SS )
ln(
)
ln(
)
ln(
)
ln( min
max
1
2
2
1 




1
hr
0.059
12
ln(40)
ln(81.5)
K 



97
.
1
1
1
1
1
12
*
059
.
0




 

e
e
R KT
L
24.2
81.5
1000
1.97
C
D
R
V
V
D
R
C
max
max
SS
SS

























05_Multiple dosing IV bolus.ppt

More Related Content

What's hot

Pharmaceuticals Dispersion theory- Suspension and Emulsion
Pharmaceuticals Dispersion theory-  Suspension and EmulsionPharmaceuticals Dispersion theory-  Suspension and Emulsion
Pharmaceuticals Dispersion theory- Suspension and EmulsionSachin Aryal
 
Buccal drug delivery system
Buccal drug delivery systemBuccal drug delivery system
Buccal drug delivery systemrasika walunj
 
GASTRO RETENTIVE DDS.pptx
GASTRO RETENTIVE DDS.pptxGASTRO RETENTIVE DDS.pptx
GASTRO RETENTIVE DDS.pptxPawanDhamala1
 
rCDDS (FUNDAMENTAL AND TYPES).pptx
rCDDS (FUNDAMENTAL AND TYPES).pptxrCDDS (FUNDAMENTAL AND TYPES).pptx
rCDDS (FUNDAMENTAL AND TYPES).pptxPawanDhamala1
 
Diffusion controlled
Diffusion controlled Diffusion controlled
Diffusion controlled Ishita Bajpai
 
Study of consolidation parameters
Study of consolidation parametersStudy of consolidation parameters
Study of consolidation parametersayesha samreen
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parametersPawanYadav285
 
Feedback Regulated Drug Delivery System
Feedback Regulated Drug Delivery SystemFeedback Regulated Drug Delivery System
Feedback Regulated Drug Delivery Systemkuldip aghera
 
Drug Release Mechanism And Kinetics
Drug Release Mechanism And KineticsDrug Release Mechanism And Kinetics
Drug Release Mechanism And KineticsVamsikrishna Reddy
 
Biological process involved in drug targetting
Biological process involved  in drug targettingBiological process involved  in drug targetting
Biological process involved in drug targettingSayeda Salma S.A.
 
Study of consolidation parameters
Study of consolidation parametersStudy of consolidation parameters
Study of consolidation parametersMehak AggarwAl
 
consoliation
consoliationconsoliation
consoliationPV. Viji
 
Physics of tablet compression
Physics of tablet compressionPhysics of tablet compression
Physics of tablet compressionUnnati Garg
 
Micro Capsules / Micro Spheres
Micro Capsules / Micro SpheresMicro Capsules / Micro Spheres
Micro Capsules / Micro SpheresPRAJAKTASAWANT33
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parametersSurbhi Narang
 
Tumour targeting and brain specific drug delivery
Tumour targeting and brain specific drug deliveryTumour targeting and brain specific drug delivery
Tumour targeting and brain specific drug deliveryMehak AggarwAl
 

What's hot (20)

Pharmaceuticals Dispersion theory- Suspension and Emulsion
Pharmaceuticals Dispersion theory-  Suspension and EmulsionPharmaceuticals Dispersion theory-  Suspension and Emulsion
Pharmaceuticals Dispersion theory- Suspension and Emulsion
 
Buccal drug delivery system
Buccal drug delivery systemBuccal drug delivery system
Buccal drug delivery system
 
GASTRO RETENTIVE DDS.pptx
GASTRO RETENTIVE DDS.pptxGASTRO RETENTIVE DDS.pptx
GASTRO RETENTIVE DDS.pptx
 
rCDDS (FUNDAMENTAL AND TYPES).pptx
rCDDS (FUNDAMENTAL AND TYPES).pptxrCDDS (FUNDAMENTAL AND TYPES).pptx
rCDDS (FUNDAMENTAL AND TYPES).pptx
 
Diffusion controlled
Diffusion controlled Diffusion controlled
Diffusion controlled
 
Study of consolidation parameters
Study of consolidation parametersStudy of consolidation parameters
Study of consolidation parameters
 
Dissolution methods
Dissolution methodsDissolution methods
Dissolution methods
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parameters
 
Feedback Regulated Drug Delivery System
Feedback Regulated Drug Delivery SystemFeedback Regulated Drug Delivery System
Feedback Regulated Drug Delivery System
 
Sr or cr formulations
Sr or cr formulationsSr or cr formulations
Sr or cr formulations
 
Drug Release Mechanism And Kinetics
Drug Release Mechanism And KineticsDrug Release Mechanism And Kinetics
Drug Release Mechanism And Kinetics
 
Biological process involved in drug targetting
Biological process involved  in drug targettingBiological process involved  in drug targetting
Biological process involved in drug targetting
 
Study of consolidation parameters
Study of consolidation parametersStudy of consolidation parameters
Study of consolidation parameters
 
M pharm dissolution
M pharm dissolutionM pharm dissolution
M pharm dissolution
 
consoliation
consoliationconsoliation
consoliation
 
Physics of tablet compression
Physics of tablet compressionPhysics of tablet compression
Physics of tablet compression
 
Micro Capsules / Micro Spheres
Micro Capsules / Micro SpheresMicro Capsules / Micro Spheres
Micro Capsules / Micro Spheres
 
Modified release drug products, Targeted Drug Delivery Systems and Biotechnol...
Modified release drug products, Targeted Drug Delivery Systems and Biotechnol...Modified release drug products, Targeted Drug Delivery Systems and Biotechnol...
Modified release drug products, Targeted Drug Delivery Systems and Biotechnol...
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parameters
 
Tumour targeting and brain specific drug delivery
Tumour targeting and brain specific drug deliveryTumour targeting and brain specific drug delivery
Tumour targeting and brain specific drug delivery
 

Similar to 05_Multiple dosing IV bolus.ppt

2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptxjiregna5
 
IV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.pptIV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.pptNoorelhuda2
 
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensAreej Abu Hanieh
 
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugCalculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugShivankan Kakkar
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV InfusionLakshmiChandran20
 
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)MdNazmulIslamTanmoy
 
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptxCalculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptxSARADPAWAR1
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacyemebetnigatu1
 
Pharmacokinetics II: Basic Concepts and Drug Clearance
Pharmacokinetics II: Basic Concepts and Drug ClearancePharmacokinetics II: Basic Concepts and Drug Clearance
Pharmacokinetics II: Basic Concepts and Drug ClearanceImhotep Virtual Medical School
 
Pharmacokinetics basics Introduced and applications
Pharmacokinetics basics Introduced  and applicationsPharmacokinetics basics Introduced  and applications
Pharmacokinetics basics Introduced and applicationsSumant Saini
 
Aminoglycoside Pharmacokinetics/Pharmacodynamics
Aminoglycoside Pharmacokinetics/PharmacodynamicsAminoglycoside Pharmacokinetics/Pharmacodynamics
Aminoglycoside Pharmacokinetics/PharmacodynamicsYazan Kherallah
 
Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya Udupa
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics Umesh Yadav
 
pharmaceutics 2 test 2_ modified delivery systems 1 Flashcards _ Quizlet.pdf
pharmaceutics 2 test 2_ modified delivery systems 1 Flashcards _ Quizlet.pdfpharmaceutics 2 test 2_ modified delivery systems 1 Flashcards _ Quizlet.pdf
pharmaceutics 2 test 2_ modified delivery systems 1 Flashcards _ Quizlet.pdfrakydt
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensSonia Barua
 
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]BADAR UDDIN UMAR
 

Similar to 05_Multiple dosing IV bolus.ppt (20)

2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx
 
IV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.pptIV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.ppt
 
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
 
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugCalculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV Infusion
 
Pharmacokinetic Models
Pharmacokinetic ModelsPharmacokinetic Models
Pharmacokinetic Models
 
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
 
Pharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosingPharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosing
 
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptxCalculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 
Pharmacokinetics II: Basic Concepts and Drug Clearance
Pharmacokinetics II: Basic Concepts and Drug ClearancePharmacokinetics II: Basic Concepts and Drug Clearance
Pharmacokinetics II: Basic Concepts and Drug Clearance
 
Pharmacokinetics basics Introduced and applications
Pharmacokinetics basics Introduced  and applicationsPharmacokinetics basics Introduced  and applications
Pharmacokinetics basics Introduced and applications
 
Aminoglycoside Pharmacokinetics/Pharmacodynamics
Aminoglycoside Pharmacokinetics/PharmacodynamicsAminoglycoside Pharmacokinetics/Pharmacodynamics
Aminoglycoside Pharmacokinetics/Pharmacodynamics
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
 
Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parameters
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics
 
pharmaceutics 2 test 2_ modified delivery systems 1 Flashcards _ Quizlet.pdf
pharmaceutics 2 test 2_ modified delivery systems 1 Flashcards _ Quizlet.pdfpharmaceutics 2 test 2_ modified delivery systems 1 Flashcards _ Quizlet.pdf
pharmaceutics 2 test 2_ modified delivery systems 1 Flashcards _ Quizlet.pdf
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimens
 
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
 

More from Noorelhuda2

Research methodology and rules for puplication
Research methodology and rules for puplicationResearch methodology and rules for puplication
Research methodology and rules for puplicationNoorelhuda2
 
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptxödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptxNoorelhuda2
 
chapter17 (1).ppt
chapter17 (1).pptchapter17 (1).ppt
chapter17 (1).pptNoorelhuda2
 
New Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxNew Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxNoorelhuda2
 
محاضرة النقابة.pptx
محاضرة النقابة.pptxمحاضرة النقابة.pptx
محاضرة النقابة.pptxNoorelhuda2
 
chapter-alkene.ppt
chapter-alkene.pptchapter-alkene.ppt
chapter-alkene.pptNoorelhuda2
 
Lec-2-Pharmacognosy.pptx
Lec-2-Pharmacognosy.pptxLec-2-Pharmacognosy.pptx
Lec-2-Pharmacognosy.pptxNoorelhuda2
 
first lecture-Pharmaceutical Analytical chemistry.ppt
first lecture-Pharmaceutical Analytical chemistry.pptfirst lecture-Pharmaceutical Analytical chemistry.ppt
first lecture-Pharmaceutical Analytical chemistry.pptNoorelhuda2
 
analytical-referance calibration.ppt
analytical-referance calibration.pptanalytical-referance calibration.ppt
analytical-referance calibration.pptNoorelhuda2
 
acid-base-equilebria.ppt
acid-base-equilebria.pptacid-base-equilebria.ppt
acid-base-equilebria.pptNoorelhuda2
 
insilicodrugdesigining-170222171857 (1).pptx
insilicodrugdesigining-170222171857 (1).pptxinsilicodrugdesigining-170222171857 (1).pptx
insilicodrugdesigining-170222171857 (1).pptxNoorelhuda2
 
cadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxcadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxNoorelhuda2
 
stereoisomersautosaved-190208040126.pptx
stereoisomersautosaved-190208040126.pptxstereoisomersautosaved-190208040126.pptx
stereoisomersautosaved-190208040126.pptxNoorelhuda2
 
ppt-lec-13-chem-260-fall-2013.pptx
ppt-lec-13-chem-260-fall-2013.pptxppt-lec-13-chem-260-fall-2013.pptx
ppt-lec-13-chem-260-fall-2013.pptxNoorelhuda2
 
group-01-stereochemistry-210827075815 (1).pptx
group-01-stereochemistry-210827075815 (1).pptxgroup-01-stereochemistry-210827075815 (1).pptx
group-01-stereochemistry-210827075815 (1).pptxNoorelhuda2
 

More from Noorelhuda2 (20)

Research methodology and rules for puplication
Research methodology and rules for puplicationResearch methodology and rules for puplication
Research methodology and rules for puplication
 
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptxödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
 
chapter17 (1).ppt
chapter17 (1).pptchapter17 (1).ppt
chapter17 (1).ppt
 
chapter11.ppt
chapter11.pptchapter11.ppt
chapter11.ppt
 
7319186.ppt
7319186.ppt7319186.ppt
7319186.ppt
 
New Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxNew Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptx
 
محاضرة النقابة.pptx
محاضرة النقابة.pptxمحاضرة النقابة.pptx
محاضرة النقابة.pptx
 
chapter-alkene.ppt
chapter-alkene.pptchapter-alkene.ppt
chapter-alkene.ppt
 
Lec-2-Pharmacognosy.pptx
Lec-2-Pharmacognosy.pptxLec-2-Pharmacognosy.pptx
Lec-2-Pharmacognosy.pptx
 
lecture-2.ppt
lecture-2.pptlecture-2.ppt
lecture-2.ppt
 
first lecture-Pharmaceutical Analytical chemistry.ppt
first lecture-Pharmaceutical Analytical chemistry.pptfirst lecture-Pharmaceutical Analytical chemistry.ppt
first lecture-Pharmaceutical Analytical chemistry.ppt
 
analytical-referance calibration.ppt
analytical-referance calibration.pptanalytical-referance calibration.ppt
analytical-referance calibration.ppt
 
acid-base-equilebria.ppt
acid-base-equilebria.pptacid-base-equilebria.ppt
acid-base-equilebria.ppt
 
10206462.ppt
10206462.ppt10206462.ppt
10206462.ppt
 
insilicodrugdesigining-170222171857 (1).pptx
insilicodrugdesigining-170222171857 (1).pptxinsilicodrugdesigining-170222171857 (1).pptx
insilicodrugdesigining-170222171857 (1).pptx
 
cadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxcadd-191129134050 (1).pptx
cadd-191129134050 (1).pptx
 
stereoisomersautosaved-190208040126.pptx
stereoisomersautosaved-190208040126.pptxstereoisomersautosaved-190208040126.pptx
stereoisomersautosaved-190208040126.pptx
 
DD.pptx
DD.pptxDD.pptx
DD.pptx
 
ppt-lec-13-chem-260-fall-2013.pptx
ppt-lec-13-chem-260-fall-2013.pptxppt-lec-13-chem-260-fall-2013.pptx
ppt-lec-13-chem-260-fall-2013.pptx
 
group-01-stereochemistry-210827075815 (1).pptx
group-01-stereochemistry-210827075815 (1).pptxgroup-01-stereochemistry-210827075815 (1).pptx
group-01-stereochemistry-210827075815 (1).pptx
 

Recently uploaded

General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 

Recently uploaded (20)

General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 

05_Multiple dosing IV bolus.ppt

  • 1. Multiple dosing: intravenous bolus administration
  • 2. Multiple IV Bolus Dose Administration  Objectives:  1) To understand drug accumulation after repeated dose administration  2) To recognize and use the integrated equations used to describe plasma concentrations versus time after multiple IV. doses  3) To calculate appropriate multiple dose drug regimen 2
  • 3. Multiple-Dosage Regimens:  After single-dose drug administration, the plasma drug level rises above and then falls below the minimum effective concentration (MEC)  decline in therapeutic effect.  To maintain prolonged therapeutic activity, many drugs are given in a multiple-dosage regimen.  The plasma levels of drugs given in multiple doses must be maintained within the narrow limits of the therapeutic window 3
  • 4.  Ideally, a dosage regimen is established for each drug to provide the correct plasma level without excessive fluctuation and drug accumulation outside the therapeutic window.  Some drugs that have a narrow therapeutic range (eg, digoxin and phenytoin) require definition of the therapeutic minimum and maximum nontoxic plasma concentrations (MEC and MTC). 4
  • 5. Multiple dosing calculations using Superposition Let: Dose 1  Conc. 1 and: Dose 2  Conc. 2 then the response system behaves according to the superposition principle if: Dose 1 +Dose 2  Conc. 1 + Conc. 2 and in that case the response system is a linear response system 5
  • 6. Multiple dosing calculations using Superposition  A patient is to be given 100 mg of a drug intravenously. Assuming that K = 0.10 hr-1 and a V = 15 L, estimate the following: 1. The half life hr hr K t 93 . 6 1 . 0 ) 2 ln( ) 2 ln( 2 / 1    6
  • 7. Multiple dosing calculations using Superposition 2. The concentration 2 hrs after the dose 3. The concentration 10 hrs after the dose mg/L 5.46 D ) 2 ( ) 2 (       t K e V t C mg/L 2.45 D ) 10 ( ) 10 (       t K e V t C 7
  • 8. Multiple dosing calculations using Superposition 4. The concentration 18 hrs after the dose mg/L 10 . 1 D ) 18 ( ) 18 (       t K e V t C 8
  • 9. 9 0 1 2 3 4 5 6 7 0 8 16 24 32 Conc. (mg/L) Time (hr)
  • 10. Multiple dosing calculations using Superposition 5. Assuming that 100 mg of the drug is administered every 8 hrs, estimate the concentration 2 hrs after the third dose using the values calculated in parts 2-4. What property of the linear systems did you use to answer this question? 10
  • 11. 0 2 4 6 8 10 12 0 8 16 24 32 Conc. (mg/L) Time (hr) Conc. After the first dose ) ( 1 t C 11
  • 12. 0 2 4 6 8 10 12 0 8 16 24 32 Conc. (mg/L) Time (hr) Conc. After the second dose ) ( 2 t C 12
  • 13. 0 2 4 6 8 10 12 0 8 16 24 32 Conc. (mg/L) Time (hr) Conc. After the third dose ) ( 3 t C 13
  • 14. 0 2 4 6 8 10 12 0 8 16 24 32 Conc. (mg/L) Time (hr) Total Conc. ) ' ( 3 t Cn 14
  • 15. 0 2 4 6 8 10 12 0 8 16 24 32 Conc. (mg/L) Time (hr) ) 2 ( ) 10 ( ) 18 ( ) 2 ' ( 3 2 1 3         t C t C t C t Cn t = 2 hrs after third dose = 10 hrs after second dose = 18 hrs after first dose 15
  • 16. Multiple dosing calculations using Superposition 5. Assuming that 100 mg of the drug is administered every 8 hrs, estimate the concentration 2 hrs after the third dose using the values calculated in parts 2-4. What property of the linear systems did you use to answer this question? mg/L 01 . 9 ) 2 ' ( 46 . 5 45 . 2 10 . 1 ) 2 ' ( ) 2 ( ) 10 ( ) 18 ( ) 2 ' ( 3 3 3 2 1 3                 t C t C t C t C t C t C n n n 16
  • 17. 1 7
  • 18. 1 8
  • 19. 1 9
  • 20. 2 0
  • 21. Multiple dosing calculations using Superposition  The principle of superposition assumes that early doses of drug do not affect the pharmacokinetics of subsequent doses.  Therefore, the blood levels after the second, third, or nth dose will overlay or superimpose the blood level attained after the (n – 1)th dose
  • 22. Multiple administration every 4 hrs Dose Number Time (hr) Dose 1 Dose 2 Dose 3 Dose 4 Total 1 0 0 0 1 21.0 21.0 3 19.8 19.8 2 4 16.9 0 16.9 5 14.3 21.0 35.3 7 10.1 19.8 29.9 3 8 8.50 16.9 0 25.4 9 7.15 14.3 21.0 42.5 11 5.06 10.1 19.8 35.0 4 12 4.25 8.50 16.9 0 29.7 13 3.58 7.15 14.3 21.0 46.0 15 2.53 5.06 10.1 19.8 37.5
  • 23. 2 3
  • 24. 2 4
  • 25. Multiple IV bolus administration  Concentration after n doses: where r: n: number of doses, T: dosing interval          ) ( D t K n e V r C KT nKT e e r      1 1
  • 26. Multiple IV bolus administration: useful equations  Maximum concentration after n doses:  Maximum concentration at steady state:        V R CSS D max        V r CN D max
  • 27. Multiple IV bolus administration: useful equations  Minimum concentration after n doses:  Minimum concentration at steady state:         KT e V R CSS D min         KT e V r CN D min
  • 28. Multiple IV bolus administration  Concentration at steady state: where R is the accumulation ratio: T: dosing interval          ) ( D t K ss e V R C KT e R    1 1
  • 30. The AUC during a dosing interval at steady state is equal to the total AUC following a single dose (For linear PK)
  • 31. AUC for a single dose is: As explained in the previous slide, Multiple IV bolus administration: useful equations  Average concentration at steady state:     0 .dt C C SS average SS  KVd X Caverage SS 0      0 τ 0 SS dose).dt C(single .dt C KVd X0 0 dose).dt C(single   
  • 32. Predicting average Css using single dose data
  • 33. Time to reach steady state conc.  The time required to reach to a certain fraction of the steady-state level is given by:  Time required to achieve steady-state depends on the half-life and is independent of the rate of dosing and the clearance  To get to 95% of the steady-state: 5 half- lives are needed  To get to 99% of the steady-state: 7 half- lives are needed ) 1 ln( 44 . 1 5 . 0 fss t n    
  • 34. Different doses regimen have the same average steady state conc: The same dosing rate (Dose/ T)
  • 35. Multiple IV bolus dosing compared to IV infusion Multiple IV bolus IV infusion
  • 36. Multiple IV bolus dosing compared to IV infusion  For IV infusion:  For multiple IV bolus (dosing rate = dose/ dosing interval):  The steady-concentration depends on the rate of dosing and the clearance clearance rate Dosing 0   KVd K Caverage SS clearance rate dosing 0    KVd X Caverage SS
  • 37. Example 1  To a patient 250 mg penicillin with t½ of 1 h and Vd of 25 L is administered every 6 h intravenously 1. Estimate Cmax, Cmin and Cav at steady state 2. Has the objective of maintaining concentration above minimum inhibitory concentration (4 mg/L) been achieved in this therapy? Elaborate! 3. How long did it take to reach 95% of Css? 4. Is the idea of giving a bolus dose to achieve Css in a shorter time feasible with regard to this drug?
  • 38. Example 1 016 . 1 1 1 1 1 6 * 693 . 0        e e R KT 1 0.5 hr 0.693 1 0.693 t 0.693 K     mg/L 10.16 25 250 1.016 V D R Cmax SS                mg/L 0.16 e 25 250 1.016 e V D R C *6 0.693 KT min SS                    mg/L 2.41 6 * 25 * 0.693 250 KVdτ X C 0 average SS   
  • 39. Example 1  Drug concentration cannot be maintained above the MIC if it is being administered every 6 h (6 x t½). Because almost 98% of the dose is out of the body at the time of the next administration. However, conventionally penicillins are given q.i.d. and it is known that they are effective. Therefore, there is no need for keeping the concentration above MIC during the entire therapy.   4.3 hrs are needed to get to 95% of Css (i.e. Css was obtained as a result of the first dose) hr 4.3 0.95) ln(1 * 1.44 fss) ln(1 t 1.44 * 1 0.5 nτ nτ       
  • 40. Example 1  The steady-state is achieved very rapidly (after the first dose). Since there is no need for accumulation, there is little justification for giving a loading dose.
  • 41. Example 2  A patient is receiving 1000 mg of sulfamethoxazole iv every 12 hours for the treatment of severe gram- negative infection. At steady state the maximum and minimum serum sulfamethoxazole concentrations were 81.5 mg/L and 40 mg/L, respectively. Estimate the values of K and VD
  • 42. Example 2 T C C t t C C K SS SS ) ln( ) ln( ) ln( ) ln( min max 1 2 2 1      1 hr 0.059 12 ln(40) ln(81.5) K     97 . 1 1 1 1 1 12 * 059 . 0        e e R KT L 24.2 81.5 1000 1.97 C D R V V D R C max max SS SS                         

Editor's Notes

  1. We give the second dose before of the completion of elimination of the first dose X node is named as maintenance dose The dosing interval is named as taw الجرعة التانية لا تبدأ من الصفر بل من بواقي الجرعة القديمة ولكنها ترتفع نفس الارتفاع
  2. Accumulation will continue until we reach a steady state where the input will equal the output Flucctuation will be between Cmin and Cmax
  3. We need to know Cmin Cmax and C average after each administration and at steady state By knowing the Cav. We can calculate the appropriate time interval and the appropriate maintenance dose